Drug Shortage Report for SODIUM ACETATE INJECTION USP
Report ID | 61485 |
Drug Identification Number | 02181746 |
Brand name | SODIUM ACETATE-OMEGA |
Common or Proper name | Sodium Acetate Injection USP |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM ACETATE |
Strength(s) | 328MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS |
Packaging size | 10 x 50 mL vial |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-09-12 |
Estimated end date | Unknown |
Actual end date | 2018-11-30 |
Shortage status | Resolved |
Updated date | 2018-12-01 |
Company comments | On a 100% preventive allocation, due to the allocation on Sodium Bicarbonate. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2018-12-01 | English | Compare |
v8 | 2018-11-30 | French | Compare |
v7 | 2018-11-30 | English | Compare |
v6 | 2018-11-30 | English | Compare |
v5 | 2018-09-18 | French | Compare |
v4 | 2018-09-18 | English | Compare |
v3 | 2018-09-18 | English | Compare |
v2 | 2018-09-14 | French | Compare |
v1 | 2018-09-14 | English | Compare |
Showing 1 to 9 of 9